Journal of Molecular and Cellular Cardiology
Volume 48, Issue 3 , Pages 483-489 , March 2010

Intracardiac renin–angiotensin system and myocardial repair/remodeling following infarction

  • Yao Sun

      Affiliations

    • Corresponding Author InformationTel./fax: +1 901 448 4921.

Received 4 May 2009 ,Revised 29 July 2009 ,Accepted 4 August 2009.

References 

  1. Ferrario CM, Trask AJ, Jessup JA. Advances in biochemical and functional roles of angiotensin-converting enzyme 2 and angiotensin-(1-7) in regulation of cardiovascular function. Am. J. Physiol. Heart Circ. Physiol. 2005;289:H2281–H2290
  2. Re RN. Tissue renin angiotensin systems. Med. Clin. North Am. 2004;88:19–38
  3. Sun Y, Weber KT. Angiotensin-converting enzyme and wound healing in diverse tissues of the rat. J. Lab. Clin. Med. 1996;127:94–101
  4. Graciano ML, Cavaglieri Rde C, Delle H, Dominguez WV, Casarini DE, Malheiros DM, et al. Intrarenal renin–angiotensin system is upregulated in experimental model of progressive renal disease induced by chronic inhibition of nitric oxide synthesis. J. Am. Soc. Nephrol. 2004;15:1805–1815
  5. Mezzano S, Droguett A, Burgos ME, Ardiles LG, Flores CA, Aros CA, et al. Renin-angiotensin system activation and interstitial inflammation in human diabetic nephropathy. Kidney Int. Suppl. 2003;64–70
  6. Sun Y, Weber KT. Angiotensin converting enzyme and myofibroblasts during tissue repair in the rat heart. J. Mol. Cell. Cardiol. 1996;28:851–858
  7. Passier RC, Smits JF, Verluyten MJ, Daemen MJ. Expression and localization of renin and angiotensinogen in rat heart after myocardial infarction. Am. J. Physiol. 1996;271:H1040–H1048
  8. Mehta PK, Griendling KK. Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system. Am. J. Physiol. Cell. Physiol. 2007;292:C82–C97
  9. Ruiz-Ortega M, Ortiz A. Angiotensin II and reactive oxygen species. Antioxid. Redox Signal. 2005;7:1258–1260
  10. Passier RC, Smits JF, Verluyten MJ, Studer R, Drexler H, Daemen MJ. Activation of angiotensin-converting enzyme expression in infarct zone following myocardial infarction. Am. J. Physiol. 1995;269:H1268–H1276
  11. Sun Y, Zhang JQ, Zhang J, Lamparter S. Cardiac remodeling by fibrous tissue after infarction in rats. J. Lab. Clin. Med. 2000;135:316–323
  12. Cleutjens JP, Verluyten MJ, Smiths JF, Daemen MJ. Collagen remodeling after myocardial infarction in the rat heart. Am. J. Pathol. 1995;147:325–338
  13. Cleutjens JP, Kandala JC, Guarda E, Guntaka RV, Weber KT. Regulation of collagen degradation in the rat myocardium after infarction. J. Mol. Cell. Cardiol. 1995;27:1281–1292
  14. Lindsey ML. MMP induction and inhibition in myocardial infarction. Heart Fail. Rev. 2004;9:7–19
  15. Lu L, Zhang JQ, Ramires FJ, Sun Y. Molecular and cellular events at the site of myocardial infarction: from the perspective of rebuilding myocardial tissue. Biochem. Biophys. Res. Commun. 2004;320:907–913
  16. Frangogiannis NG, Smith CW, Entman ML. The inflammatory response in myocardial infarction. Cardiovasc. Res. 2002;53:31–47
  17. Frangogiannis NG. The immune system and cardiac repair. Pharmacol. Res. 2008;58:88–111
  18. Lu L, Chen SS, Zhang JQ, Ramires FJ, Sun Y. Activation of nuclear factor-kappaB and its proinflammatory mediator cascade in the infarcted rat heart. Biochem. Biophys. Res. Commun. 2004;321:879–885
  19. Francis J, Zhang ZH, Weiss RM, Felder RB. Neural regulation of the proinflammatory cytokine response to acute myocardial infarction. Am. J. Physiol. Heart Circ. Physiol. 2004;287:H791–H797
  20. van Amerongen MJ, Harmsen MC, van Rooijen N, Petersen AH, van Luyn MJ. Macrophage depletion impairs wound healing and increases left ventricular remodeling after myocardial injury in mice. Am. J. Pathol. 2007;170:818–829
  21. Barrientos S, Stojadinovic O, Golinko MS, Brem H, Tomic-Canic M. Growth factors and cytokines in wound healing. Wound. Repair. Regen. 2008;16:585–601
  22. Sun Y, Zhang JQ, Zhang J, Ramires FJ, Angiotensin II. transforming growth factor-beta1 and repair in the infarcted heart. J. Mol. Cell. Cardiol. 1998;30:1559–1569
  23. Gabbiani G, Ryan GB, Majne G. Presence of modified fibroblasts in granulation tissue and their possible role in wound contraction. Experientia. 1971;27:549–550
  24. Desmouliere A, Geinoz A, Gabbiani F, Gabbiani G. Transforming growth factor-beta 1 induces alpha-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts. J. Cell. Biol. 1993;122:103–111
  25. Sun Y, Zhang J, Zhang JQ, Weber KT. Renin expression at sites of repair in the infarcted rat heart. J. Mol. Cell. Cardiol. 2001;33:995–1003
  26. Sun Y, Weber KT. Angiotensin II receptor binding following myocardial infarction in the rat. Cardiovasc. Res. 1994;28:1623–1628
  27. Yamagishi H, Kim S, Nishikimi T, Takeuchi K, Takeda T. Contribution of cardiac renin–angiotensin system to ventricular remodelling in myocardial-infarcted rats. J. Mol. Cell. Cardiol. 1993;25:1369–1380
  28. Falkenhahn M, Franke F, Bohle RM, Zhu YC, Stauss HM, Bachmann S, et al. Cellular distribution of angiotensin-converting enzyme after myocardial infarction. Hypertension. 1995;25:219–226
  29. Sun Y, Weber KT. Cells expressing angiotensin II receptors in fibrous tissue of rat heart. Cardiovasc. Res. 1996;31:518–525
  30. Hodsman GP, Kohzuki M, Howes LG, Sumithran E, Tsunoda K, Johnston CI. Neurohumoral responses to chronic myocardial infarction in rats. Circulation. 1988;78:376–381
  31. Ratajska A, Campbell SE, Sun Y, Weber KT. Angiotensin II associated cardiac myocyte necrosis: role of adrenal catecholamines. Cardiovasc. Res. 1994;28:684–690
  32. Sun Y, Ratajska A, Zhou G, Weber KT. Angiotensin-converting enzyme and myocardial fibrosis in the rat receiving angiotensin II or aldosterone. J. Lab. Clin. Med. 1993;122:395–403
  33. Lijnen PJ, Petrov VV. Role of intracardiac renin–angiotensin–aldosterone system in extracellular matrix remodeling. Methods Find. Exp. Clin. Pharmacol. 2003;25:541–564
  34. Sun Y, Cleutjens JP, Diaz-Arias AA, Weber KT. Cardiac angiotensin converting enzyme and myocardial fibrosis in the rat. Cardiovasc. Res. 1994;28:1423–1432
  35. Takahashi M, Suzuki E, Takeda R, Oba S, Nishimatsu H, Kimura K, et al. Angiotensin II and tumor necrosis factor-alpha synergistically promote monocyte chemoattractant protein-1 expression: roles of NF-kappaB, p38, and reactive oxygen species. Am. J. Physiol. Heart Circ. Physiol. 2008;294:H2879–H2888
  36. Lu L, Quinn MT, Sun Y. Oxidative stress in the infarcted heart: role of de novo angiotensin II production. Biochem. Biophys. Res. Commun. 2004;325:943–951
  37. Sirker A, Zhang M, Murdoch C, Shah AM. Involvement of NADPH oxidases in cardiac remodelling and heart failure. Am. J. Nephrol. 2007;27:649–660
  38. Agarwal R, Campbell RC, Warnock DG. Oxidative stress in hypertension and chronic kidney disease: role of angiotensin II. Semin. Nephrol. 2004;24:101–114
  39. Wolf G. Free radical production and angiotensin. Curr. Hypertens. Rep. 2000;2:167–173
  40. Heffelfinger SC. The renin angiotensin system in the regulation of angiogenesis. Curr. Pharm. Des. 2007;13:1215–1229
  41. Fujita M, Hayashi I, Yamashina S, Itoman M, Majima M. Blockade of angiotensin AT1a receptor signaling reduces tumor growth, angiogenesis, and metastasis. Biochem. Biophys. Res. Commun. 2002;294:441–447
  42. Sasaki K, Murohara T, Ikeda H, Sugaya T, Shimada T, Shintani S, et al. Evidence for the importance of angiotensin II type 1 receptor in ischemia-induced angiogenesis. J. Clin. Invest. 2002;109:603–611
  43. Shimizu T, Okamoto H, Chiba S, Matsui Y, Sugawara T, Akino M, et al. VEGF-mediated angiogenesis is impaired by angiotensin type 1 receptor blockade in cardiomyopathic hamster hearts. Cardiovasc. Res. 2003;58:203–212
  44. Kim JH, Kim JH, Yu YS, Cho CS, Kim KW. Blockade of angiotensin II attenuates VEGF-mediated blood-retinal barrier breakdown in diabetic retinopathy. J. Cereb. Blood Flow Metab. 2009;29:621–628
  45. Skaletz-Rorowski A, Pinkernell K, Sindermann JR, Schriever C, Muller JG, Eschert H, et al. Angiotensin AT1 receptor upregulates expression of basic fibroblast growth factor, basic fibroblast growth factor receptor and coreceptor in human coronary smooth muscle cells. Basic. Res. Cardiol. 2004;99:272–278
  46. Toko H, Zou Y, Minamino T, Masaya M, Harada M, Nagai T, et al. Angiotensin II type 1a receptor is involved in cell infiltration, cytokine production, and neovascularization in infarcted myocardium. Arterioscler. Thromb. Vasc. Biol. 2004;24:664–670
  47. de Boer RA, Pinto YM, Suurmeijer AJ, Pokharel S, Scholtens E, Humler M, et al. Increased expression of cardiac angiotensin II type 1 (AT(1)) receptors decreases myocardial microvessel density after experimental myocardial infarction. Cardiovasc. Res. 2003;57:434–442
  48. Jugdutt BI, Schwarz-Michorowski BL, Khan MI. Effect of long-term captopril therapy on left ventricular remodeling and function during healing of canine myocardial infarction. J. Am. Coll. Cardiol. 1992;19:713–721
  49. De Carvalho Frimm C, Sun Y, Weber KT. Angiotensin II receptor blockade and myocardial fibrosis of the infarcted rat heart. J. Lab. Clin. Med. 1997;129:439–446
  50. Oishi Y, Ozono R, Yano Y, Teranishi Y, Akishita M, Horiuchi M, et al. Cardioprotective role of AT2 receptor in postinfarction left ventricular remodeling. Hypertension. 2003;41:814–818
  51. Chung O, Unger T, Angiotensin II. receptor blockade and end-organ protection. Am. J. Hypertens. 1999;12:150S–156S
  52. Averill DB, Ishiyama Y, Chappell MC, Ferrario CM. Cardiac angiotensin-(1–7) in ischemic cardiomyopathy. Circulation. 2003;108:2141–2146
  53. Thai HM, Van HT, Gaballa MA, Goldman S, Raya TE. Effects of AT1 receptor blockade after myocardial infarct on myocardial fibrosis, stiffness, and contractility. Am. J. Physiol. 1999;276:H873–H880
  54. Nakamura Y, Yoshiyama M, Omura T, Yoshida K, Izumi Y, Takeuchi K, et al. Beneficial effects of combination of ACE inhibitor and angiotensin II type 1 receptor blocker on cardiac remodeling in rat myocardial infarction. Cardiovasc. Res. 2003;57:48–54
  55. Gross O, Schulze-Lohoff E, Koepke ML, Beirowski B, Addicks K, Bloch W, et al. Antifibrotic, nephroprotective potential of ACE inhibitor vs AT1 antagonist in a murine model of renal fibrosis. Nephrol. Dial. Transplant. 2004;19:1716–1723
  56. Molteni A, Moulder JE, Cohen EF, Ward WF, Fish BL, Taylor JM, et al. Control of radiation-induced pneumopathy and lung fibrosis by angiotensin-converting enzyme inhibitors and an angiotensin II type 1 receptor blocker. Int. J. Radiat. Biol. 2000;76:523–532

PII: S0022-2828(09)00326-5

doi: 10.1016/j.yjmcc.2009.08.002

Journal of Molecular and Cellular Cardiology
Volume 48, Issue 3 , Pages 483-489 , March 2010

Article Tools

* Image Usage & Resolution